Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.
-
Upload
alisha-banks -
Category
Documents
-
view
227 -
download
0
Transcript of Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.
![Page 1: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/1.jpg)
Reproductive Hormonal Pharmacology
Douglas Danforth, Ph.D.The Ohio State University
![Page 2: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/2.jpg)
Objectives
1. Describe the feedback mechanisms related to stimulation and inhibition of the hypothalamic, pituitary, and gonadal hormones involved in male and female reproduction
2. Describe the effects, medical uses, and consequences of abuse and androgens3. Describe the effects and consequences of testosterone insufficiency or suppression4. Describe the medical uses of antiandrogens and their mechanism of action
Explain the endocrinology of the male reproductive system and the physiological processes of testosterone production and spermatogenesis
1. Describe the difference types of estrogens and progestins, their effects, and their medical uses2. Describe the medical uses of SERM’s and antiprogestins, as well as possible problems associated with
their use3. Describe the mechanism of action of aromatase inhibitors and their use in cancer patients
Describe the interplay of feedback mechanisms that affect the menstrual cycle.
![Page 3: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/3.jpg)
![Page 4: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/4.jpg)
![Page 5: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/5.jpg)
![Page 6: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/6.jpg)
leuprolide (GnRH Agonist)
NH2pGlu His Trp Ser Tyr Gly Leu Arg Pro Gly
NHEtpGlu His Trp Ser Tyr Leu Arg ProD-Leu
NH2
NAcD2Nal D4CIPhe
D3Pal Ser Tyr
DhArg(Et2) hArg (Et2)
Pro D-AlaLeu
Antagon (GnRH Antagonist)
1 2 3 4 5 6 7 8 9 10AminoAcidNumber
GnRH
![Page 7: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/7.jpg)
GnRH
Agonist
U
U
Short Term
LH
FSH
Effects of GnRH AgonistU
U
UU
U
U
U
U
U
U
U
U
UU
U
U
U
U
UU U
U
U
U
UU
U
U
U
UU
Long TermU
U
UUU
U
U
U
UU U
U
![Page 8: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/8.jpg)
Days
T, E
2 , P
4
LH, F
SH
0
10
20
30
0
10
20
30
Hours
E 2 , P
4
LH, F
SH
Start Administration
GnRH Agonist
GnRH Antagonist
![Page 9: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/9.jpg)
X
Short Term
X
X
X
XX
X
X
X
U
UU
U
U
U
U
U
U
U
U
X
X
XX
X
X
X
X
Long Term
X
X
X
X
XX
X
X
X
U
U
U
U
U
U
U
U
U
U
X
X
X
X
XX
XX
GnRH
Antagonist
U
LH
FSH
Effects of GnRH Antagonist
![Page 10: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/10.jpg)
Days
T, E
2 , P
4
LH, F
SH
0
10
20
30
0
10
20
30
Hours
T, E
2 , P
4
LH, F
SH
Start Administration
GnRH Agonist
GnRH Antagonist
![Page 11: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/11.jpg)
Stimulation – Pulsatile GnRH or GnRH agonist• Delayed puberty• Ovulation induction in hypogonadotropic hypogonadism
Suppression – Continuous GnRH agonist – side effect of bone loss due to hypoestrogenism caused by ↓ FSH/LH.
• Prostate/Breast Cancer • Endometriosis• Precocious puberty
GnRH analogs – clinical uses
GnRH Agonist
GnRH Antagonist
Suppression – Daily GnRH Antagonist• Assisted Reproduction Technologies – IVF – prevent LH surge• Prostate Cancer – suppress testicular androgen production
![Page 12: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/12.jpg)
Gonadotropins– clinical uses
• Stimulation of spermatogenesis• rFSH vs hMG vs hCG
• Assisted Reproduction Technologies• FSH for gonadal stimulation• hCG vs LH for ovulation induction
![Page 13: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/13.jpg)
Progestin(Progesterone)
Estrogen(Estradiol)
Testosterone Dihydrotestosterone
5-α reductase
Type 1
Type 2
• Skin, liver• 1/3 circulating DHT
• Reproductive tissues (prostate, penis, scrotum), skin
• 2/3 circulating DHT
![Page 14: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/14.jpg)
Androgen effects
![Page 15: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/15.jpg)
Male Hypogonadism – Low T• Low libido• Decreased erection• Alopecia• Bone loss• Gynecomastia• Decreased testicular size
Side effects• Infertility – feedback suppression of LH/FSH• Gynecomastia – T is precursor for E
![Page 16: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/16.jpg)
• Androgens – abusesPerformance enhancement
• Androstenedione• Precursor for T• Dietary supplement
• Dihydrotestosterone• Much more potent than T
Side effects• Infertility• liver damage• hypertension• heart disease• prostatic hypertrophy• testicular atrophy
![Page 17: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/17.jpg)
Antiandrogens5 α-reductase inhibitors• Finasteride/Dutasteride
• BPH, alopecia
Androgen antagonists• Flutamide/bicalutamide/nilutamide
• Prostate Cancer
• Spironolactone• Androgen and aldosterone antagonist• Also inhibits 17 α hydroxylase • ↓ T and androstenedione, ↑ Na
• Hirsutism and hypertension
![Page 18: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/18.jpg)
![Page 19: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/19.jpg)
Estrogen
• Oral contraceptives – usually include progestin to block proliferation• Hormone Replacement Therapy – need progestin if intact uterus
• Hot flashes• Vaginal dryness• Osteoporosis
• Infertility Treatment – followed by progestin to prepare uterus for implantation in frozen embryo transfer cycles
Estrogen – clinical uses
Estrogen – abuses?
![Page 20: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/20.jpg)
Clinical Profile of Ideal Selective Estrogen Receptor Modulator (SERM)
Site of action Effect Clinical outcome
Bone ER agonist Prevent osteoporosisReduce fracture risk
CNS ER agonist Reduce hot flushes and other menopausal symptoms
Cardiovascular/lipids ER agonist Lower cardiovascular risk
Breast ER neutral or antagonist
Prevent or no increase in breast cancer (and limit proliferation)
Uterus ER neutral or antagonist
Prevent or no increase in endometrial cancer (and limit proliferation)
Menopause. 16(3): 609–615, 2009
![Page 21: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/21.jpg)
Raloxifene (Evista)
Tamoxifen (Nolvadex)
Clomiphene (Clomid)
Tissue Selective Estrogen Complex
(TESC)
Bone +Breast -Uterus -
Breast -Uterus +
CNS - Bazedoxifene• Breast – • Uterus – Estrogen• Bone +
Selective Estrogen Receptor Modulator (SERMS)
bazedoxifene
+
![Page 22: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/22.jpg)
Aromatase Inhibitors
Competitive (reversible) inhibitors• Anastrazole• Letrozole
Irreversible (covalent) inhibitors• Exemestane• Formestane
![Page 23: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/23.jpg)
Progesterone Effects• Gonadotropin Secretion• Cervical mucus production• Uterus• Mammary Gland• Basal Body Temperature
Progesterone
Progesterone antagonist• Mifepristone (RU486)
• Blocks P receptor in endometrium• Causes endometrium to slough• Combined with prostaglandin for
pregnancy termination
Progesterone Clinical Uses• Gonadotropin Secretion• Combined with E for OC• P only mini-pill – thicken cervical mucus• Long acting Injectable P – inhibit ovulation
• Uterus• HRT to stop endometrial proliferation
![Page 24: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/24.jpg)
GnRH
Testosterone
GnRH agonist – short term flare, long term suppressionGnRH antagonist – immediate suppression
LH/hCG – induce ovulationFSH – follicle simulation for IVF/ARTFSH/hMG – stimulate spermatogenesis
Estrogen
Aromatase inhibitors
Gene transcription
SERMs
Progesterone
Gene transcription
Testosterone
Dihydro-testosterone
Gene transcription
Mifepristone
5 α reductaseinhibitors
Androgen ReceptorAntagonists
Pituitary
![Page 25: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/25.jpg)
Quiz 1
![Page 26: Reproductive Hormonal Pharmacology Douglas Danforth, Ph.D. The Ohio State University.](https://reader036.fdocuments.in/reader036/viewer/2022081508/56649e7b5503460f94b7c468/html5/thumbnails/26.jpg)
SurveyWe would appreciate your feedback on this module. Click on the button below to complete a brief survey. Your responses and comments will be shared with the module’s author, the LSI EdTech team, and LSI curriculum leaders. We will use your feedback to improve future versions of the module.
The survey is both optional and anonymous and should take less than 5 minutes to complete.
Survey